Delivery Order SPE2DB22D1103-SPE2DB25FTNG5

Award Date 5/23/25
Potential Completion Date 5/27/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Prochlorperazine 10 mg/2 ml vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,535.20, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $7,245.95 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 20, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,577.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which has a total potential value of $999,999,999.00 and provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government agencies through...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $2,500.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 5, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of 4556527817 APREPITANT 80 MG CAPSULE UU 2S to the Defense Logistics Agency (DLA). The $3,531.50 firm fixed-price contract has a completion date of March 11, 2022. This delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $3,661.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for 4568143819 - ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of May 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The $5,342.92 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024. The contract has an ultimate completion date of December 20, 2024 and is not designated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, SPE2DX15D3017|SPE2DX24F0HWU, was issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulance 3 mg tablets, a pharmaceutical product, with a ceiling value of $1,163.92 and a completion date of October 24, 2023. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract....
This federal contract award is for the delivery of ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $12,007.51 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 14, 2025. The contract has a completion date of January 15, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTNG5
    Delivery Order

This federal contract award is for the delivery of PRUCALOPRIDE 2 MG TABLET UU 30S to the Defense Logistics Agency, a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,719.31. The contract is a Firm Fixed Price Delivery Order with a completion date of May 27, 2025. This award is not a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) vehicle valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. Amerisourcebergen Drug Corp is a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/22/25, 10:00 AM